Translational Financial Statements From 2010 to 2025

TDAC Stock  USD 10.46  0.01  0.1%   
Translational Development's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Translational Development's valuation are provided below:
Market Capitalization
220 M
Earnings Share
(0.03)
Translational Development Acquisition does not presently have any fundamental trend indicators for analysis.
Check Translational Development financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Translational Development's main balance sheet or income statement drivers, such as Depreciation And Amortization of 56.5 K, Selling General Administrative of 9.6 B or Other Operating Expenses of 275.9 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0025 or PTB Ratio of 0.25. Translational financial statements analysis is a perfect complement when working with Translational Development Valuation or Volatility modules.
Check out the analysis of Translational Development Correlation against competitors.

Translational Development Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets183.8 M175 M22.8 M
Slightly volatile
Short and Long Term Debt Total6.4 T6.1 T782.9 B
Slightly volatile
Total Current Liabilities314.5 K210.3 K437.9 K
Slightly volatile
Cash460.1 K438.2 K58.1 K
Slightly volatile
Cash And Short Term Investments460.1 K438.2 K58.1 K
Slightly volatile
Common Stock Shares Outstanding3.2 M3.6 MM
Slightly volatile
Liabilities And Stockholders Equity183.8 M175 M22.8 M
Slightly volatile
Other Current Assets145.2 K243.9 K79.8 K
Slightly volatile
Total Liabilities6.6 M6.2 M1.2 M
Slightly volatile
Short and Long Term Debt333.6 K399.6 K278 K
Slightly volatile
Total Current Assets682.7 K650.2 K127.5 K
Slightly volatile
Capital Stock183.1 M174.4 M22.3 M
Slightly volatile
Short Term Debt6.4 T6.1 T782.9 B
Slightly volatile
Common Stock19.2 B18.3 B2.3 B
Slightly volatile
Accounts Payable9.6 K16.2 K2.7 K
Slightly volatile
Good Will7.2 T8.2 T8.9 T
Slightly volatile
Accumulated Other Comprehensive Income13.5 B15.2 B16.6 B
Slightly volatile
Intangible Assets10.1 T11.3 T12.3 T
Slightly volatile

Translational Development Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization56.5 K63.6 K69.3 K
Slightly volatile
Selling General Administrative9.6 B9.1 B1.2 B
Slightly volatile
Other Operating Expenses275.9 K196.4 K117.3 K
Slightly volatile
Total Operating Expenses275.9 K196.4 K117.3 K
Slightly volatile
Interest Expense406.9 M457.7 M499 M
Slightly volatile
Gross Profit595.9 M670.4 M731 M
Slightly volatile
Cost Of Revenue256.7 M288.8 M314.9 M
Slightly volatile

Translational Development Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Cashflows From Financing Activities8.4 MM1.5 M
Slightly volatile
End Period Cash Flow460.1 K438.2 K58.1 K
Slightly volatile
Begin Period Cash Flow1.7 KK2.2 K
Slightly volatile
Dividends Paid100.3 K112.8 K123 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.00.00.0
Slightly volatile
Dividend Yield0.00250.00280.003
Slightly volatile
Average PayablesK7.8 K8.6 K
Slightly volatile
EV To Sales4.585.165.6257
Slightly volatile
Payables Turnover15.9 M17.8 M19.4 M
Slightly volatile
Sales General And Administrative To Revenue6.857.718.4018
Slightly volatile
Cash Per Share0.110.10820.0141
Slightly volatile
Days Payables Outstanding0.00.00.0
Slightly volatile
Income Quality12.5911.99023.2036
Slightly volatile
Intangibles To Total Assets98.9 K111.2 K121.3 K
Slightly volatile
Current Ratio3.253.09190.4925
Slightly volatile
Capex Per Share0.00.00.0
Slightly volatile
Revenue Per Share210.5 K236.8 K258.2 K
Slightly volatile
Interest Debt Per Share1.7 M1.6 M209.4 K
Slightly volatile
Debt To Assets36.7 K34.9 K4.5 K
Slightly volatile
Days Of Payables Outstanding0.00.00.0
Slightly volatile
Ebt Per Ebit0.290.330.3552
Slightly volatile
Quick Ratio3.253.09190.4925
Slightly volatile
Cash Ratio2.192.08350.2713
Slightly volatile
Debt Ratio36.7 K34.9 K4.5 K
Slightly volatile
Price Sales Ratio0.00.00.0
Slightly volatile
Asset Turnover4.9 K5.5 KK
Slightly volatile
Gross Profit Margin0.560.630.6859
Slightly volatile

Translational Fundamental Market Drivers

About Translational Development Financial Statements

Translational Development stakeholders use historical fundamental indicators, such as Translational Development's revenue or net income, to determine how well the company is positioned to perform in the future. Although Translational Development investors may analyze each financial statement separately, they are all interrelated. For example, changes in Translational Development's assets and liabilities are reflected in the revenues and expenses on Translational Development's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Translational Development Acquisition. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue288.8 M256.7 M
Sales General And Administrative To Revenue 7.71  6.85 
Revenue Per Share236.8 K210.5 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Translational Development is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Translational Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Translational Development Acquisition Stock. Highlighted below are key reports to facilitate an investment decision about Translational Development Acquisition Stock:
Check out the analysis of Translational Development Correlation against competitors.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Diversified Capital Markets space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Translational Development. If investors know Translational will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Translational Development listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.03)
The market value of Translational Development is measured differently than its book value, which is the value of Translational that is recorded on the company's balance sheet. Investors also form their own opinion of Translational Development's value that differs from its market value or its book value, called intrinsic value, which is Translational Development's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Translational Development's market value can be influenced by many factors that don't directly affect Translational Development's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Translational Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Translational Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Translational Development's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.